pharmaphorum

AUGUST 25, 2021

Researchers in the US have found that older people are far more likely to engage with digital physiotherapy programmes digitally than those in younger age groups. Gen Xers, working-age baby boomers and retirees – collectively the over-41 age bracket – were more likely to start a musculoskeletal (MSK) programme delivered via digital channels than Gen Zers and millennials, according to Hinge Health, whose back and joint pain programme was used in the study.

145

145

Outsourcing Pharma

AUGUST 23, 2021

Thanks in part to grants from the Gates Foundation, the company has come up with a bioerodible implant that combines HIV prevention and birth control.

119

119

Pharma Times

AUGUST 25, 2021

The ZOE COVID Study app assessed data on positive COVID-19 PCR test results between May and July 2021

Vaccines 127

Vaccines 127

Drug Patent Watch

AUGUST 27, 2021

Annual Drug Patent Expirations for EPCLUSA Epclusa is a drug marketed by Gilead Sciences Inc and is included in two NDAs. It is available from one supplier. There are twenty-six…. The post New patent for Gilead Sciences drug EPCLUSA appeared first on DrugPatentWatch - Make Better Decisions.

98

98

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

AUGUST 24, 2021

Digital health startup Breathe Well-being has raised $5.5 million in first-round financing, which it will use to scale up its clinical tool that it says helps people “prevent, manage and reverse type 2 diabetes.” . The Series A – led by US venture capital group Accel with participation from General Catalyst and Scott Shleifer, global managing director of hedge fund Tiger Global, which is a highly active investor in privately-held tech firms.

Diabetes 125

Diabetes 125

Outsourcing Pharma

AUGUST 24, 2021

The regional US healthcare system will collaborate with the health intelligence specialist to advance precision medicine focused on oncological care.

105

105

Drug Patent Watch

AUGUST 24, 2021

Annual Drug Patent Expirations for SYNJARDY Synjardy is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from one supplier. There are six patents…. The post New patent for Boehringer Ingelheim drug SYNJARDY appeared first on DrugPatentWatch - Make Better Decisions.

98

98

pharmaphorum

AUGUST 26, 2021

A merger between two digital mental health companies – Headspace and Ginger – will create a $3 billion giant in a category that has been growing at breakneck speed as a result of the COVID-19 pandemic. The deal brings together Headspace’s meditation and mindfulness app – used by millions of people around the world – and Ginger’s platform which provides therapy and psychiatric support as an on-demand, video-based service.

120

120

NY Times

AUGUST 21, 2021

“You are not a horse,” the Food and Drug Administration said. “Stop it.”.

Immunity 145

Immunity Immunization Vaccines 145

Pharma Times

AUGUST 26, 2021

Early stage research found 5-azacytidine may be used to treat 'devastating' disease

137

137

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Drug Patent Watch

AUGUST 24, 2021

Annual Drug Patent Expirations for SYNJARDY+XR Synjardy Xr is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are five…. The post New patent for Boehringer Ingelheim drug SYNJARDY XR appeared first on DrugPatentWatch - Make Better Decisions.

98

98

pharmaphorum

AUGUST 26, 2021

Everyone is familiar with the phrase ‘patient-centricity’ but, where it might once have been seen as a ‘checkbox exercise’, it has gained preeminent status in the era of COVID-19, says Prime Global’s Ross Jackson. The pandemic has transformed many aspects of our industry and one area that change has come to is patient engagement within clinical trials, where it would now seem unusual were we to not consider the patient voice when it comes to recruiting trial participants.

Drug Development 104

Drug Development Communication 104

Outsourcing Pharma

AUGUST 23, 2021

The drug discovery company reportedly used AI-powered drug discovery to come up with a promising preclinical candidate for treatment of the kidney ailment.

98

98

Pharma Times

AUGUST 24, 2021

Biologics License Application approved to prevent COVID-19 in individuals 16 years of age and older

Vaccines 123

Vaccines 123

Drug Patent Watch

AUGUST 23, 2021

Annual Drug Patent Expirations for JARDIANCE Jardiance is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from four suppliers. There are six patents…. The post New patent for Boehringer Ingelheim drug JARDIANCE appeared first on DrugPatentWatch - Make Better Decisions.

98

98

pharmaphorum

AUGUST 25, 2021

Just a month after getting approval for its new pneumococcal vaccine Vaxneuvance in adults, Merck & Co has reported positive trial results in children that will ramp up the pressure on Pfizer and its market-leading Prevnar franchise. The 15-valent conjugate vaccine was at least as effective as Pfizer’s 13-valent Prevnar 13 in the study, which involved infants up to 15 months old, and will form the basis of regulatory filing to extend the label for Vaxneuvance later this year, according

Vaccines 104

Vaccines Labelling Immunity Immunization 104

Outsourcing Pharma

AUGUST 24, 2021

According to the study, the countryâs overreliance on pharmaceutical ingredients manufactured in overseas factories threatens national security and health.

98

98

Pharma Times

AUGUST 23, 2021

Investment will be used to support the development of disease modifying drugs to treat Parkinson’s disease

114

114

NY Times

AUGUST 23, 2021

The move was expected to kick off a round of new vaccination mandates from hospitals, schools and private companies.

Vaccines 98

Vaccines Hospitals Immunity Immunization 98

pharmaphorum

AUGUST 24, 2021

One of the most common and challenging side effects for people undergoing dialysis for chronic kidney disease – chronic itching – now has an FDA-approved treatment. The US regulator has cleared Cara Therapeutics’ Korsuva (difelikefalin) as an injectable treatment for chronic itching, also known as pruritus, in these patients after a priority review.

104

104

Outsourcing Pharma

AUGUST 24, 2021

The CRO has launched an initiative that offers help navigating regulatory issues for ultra-rare disease patient advocacy groups that demonstrate a need.

98

98

Pharma Times

AUGUST 27, 2021

Accelerated assessment granted for company’s lead product candidate ganaxolone

123

123

NY Times

AUGUST 25, 2021

Congress appropriated $16 billion to ramp up Covid-19 countermeasures, but a new report found that the Biden administration had spent very little of it on expanding vaccine manufacturing capacity.

Vaccines 60

Vaccines Immunity Immunization 60

pharmaphorum

AUGUST 23, 2021

The COVID-19 pandemic accelerated the development of mRNA-based vaccines, and its influence has now extended to DNA-based shots as well, with Zydus Cadila’s ZyCoV-D getting emergency use authorisation in India. This is the first DNA vaccine ever to receive regulatory authorisation anywhere in the world, the first COVID-19 jab approved in India to treat children aged 12 and above as well as adults, as well as the first coronavirus shot that can be administered using needle-free delivery.

Vaccines 98

Vaccines Immunity Immunization 98

Outsourcing Pharma

AUGUST 23, 2021

The two firms will work together on solutions to connect de-identified, first-party data to real-world data to help advance precision medicine development.

98

98

Pharma Times

AUGUST 23, 2021

Talazoparib delayed disease progression in Phase II trial

133

133

NY Times

AUGUST 24, 2021

Female entrepreneurs said they were constantly compared to Ms. Holmes, the disgraced founder of Theranos, who faces trial soon.

66

66

pharmaphorum

AUGUST 22, 2021

The FDA has issued a safety alert about the use of robot-assisted surgical (RAS) devices for use in mastectomy procedures, pointing out that their safety and efficacy have not been established. The move comes amid reports that some people are being offered RAS for the prevention or treatment of breast cancer, sometimes as part of a clinical trial, even though many of the studies are being undertaken “without the FDA oversight required.” RAS devices – which enable surgeons to use comp

93

93

Outsourcing Pharma

AUGUST 26, 2021

A study conducted by trial tech firms Curedatis and Climedo Health reveals what trial professionals view as challenges and opportunities in digitalization.

96

96

Pharma Times

AUGUST 26, 2021

Up to 8,000 people per day can access the tests

138

138

NY Times

AUGUST 24, 2021

Female entrepreneurs said they were constantly compared to Ms. Holmes, the disgraced founder of Theranos, who faces trial soon.

65

65

pharmaphorum

AUGUST 23, 2021

The NHS’ much-vaunted GP data-sharing initiative looks to be on a prolonged hiatus, with at least one report suggesting it has been hit by 1.2 million people choosing to opt out of the scheme in the space of two months. The General Practice Data for Planning and Research (GPDPR) is now on hold “with no new date for implementation,” according to The Observer newspaper.

Medical Records 87

Medical Records Documentation Pharmaceutical Companies Pharmaceutical Companies 87

Outsourcing Pharma

AUGUST 26, 2021

The International Vaccine Institute (IVI) and Bharat Biotech have started a Phase 2/3 clinical trial for a chikungunya vaccine candidate in Costa Rica.

Vaccines 59

Vaccines 59

Pharma Times

AUGUST 25, 2021

Participants will be given Pfizer, Moderna or Novavax vaccines

Vaccines 126

Vaccines 126

Drug Patent Watch

AUGUST 27, 2021

Annual Drug Patent Expirations for NURTEC+ODT Nurtec Odt is a drug marketed by Biohaven Pharm and is included in one NDA. There are two patents protecting this drug. NURTEC ODT…. The post New patent for Biohaven Pharm drug NURTEC ODT appeared first on DrugPatentWatch - Make Better Decisions.

52

52